Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04603378 · ClinicalTrials.gov registry record · NA
A Clinical Study to Assess the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects
A NA study, sponsored by Kaleido Biosciences.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT04603378 is a NA study that has completed, run by Kaleido Biosciences. The registered enrollment target is 47 participants.
The verdict
NCT04603378, a NA study, has completed, sponsored by Kaleido Biosciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
This exploratory, randomized, double-blind, placebo-controlled study aims to explore the effect of novel glycans on nitrogen metabolism in the gut in healthy subjects using a stable isotope.
Interventions
- OTHER Maltodextrin
- OTHER KB195
- OTHER Polydextrose
- OTHER Pullulan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2017-09-18 |
| Est. Completion | 2017-11-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04603378
The ClinicalTrials.gov registry entry for NCT04603378 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaleido Biosciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Maltodextrin is the first listed.
NCT04603378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04603378 about?
NCT04603378 is a clinical study titled "A Clinical Study to Assess the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects". This exploratory, randomized, double-blind, placebo-controlled study aims to explore the effect of novel glycans on nitrogen metabolism in the gut in healthy subjects using a stable isotope.
What is the current status of trial NCT04603378?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2017-09-18. Estimated completion is 2017-11-28.
What interventions are being tested in trial NCT04603378?
The interventions under investigation include: Maltodextrin (OTHER), KB195 (OTHER), Polydextrose (OTHER), Pullulan (OTHER).
Who is sponsoring clinical trial NCT04603378?
This trial is sponsored by Kaleido Biosciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.